Philips (PHG) said Tuesday it has received US Food and Drug Administration clearance for its reusable SpO2 clip sensor.
The sensor is designed to improve signal quality and measurement consistency for oxygen saturation monitoring across a broad range of patients and clinical settings, the company said.
Philips said the sensor will be available in select markets later this year.
Philips shares were down 1.3% in early Tuesday trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments